东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01558 东阳光长江药业

交易中 05-06 13:44:35

12.900

+0.360

+2.87%

最高12.940	最低12.340	成交量400.61万
今开12.540	昨收12.540	日振幅4.78%
总市值113.52亿	流通市值84.37亿	总股本8.80亿
成交额5,079万	换手率0.61%	流通股本6.54亿
市净率1.24	ROE5.87%	每股收益0.59
52周最高13.300	52周最低7.920	市盈率21.89
股息0.00	股息收益率0.00	ROA3.32%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01558","market":"HK","secType":"STK","nameCN":"东阳光长江药业","latestPrice":12.9,"timestamp":1746510265430,"preClose":12.54,"halted":0,"volume":4006134,"delay":0,"floatShares":654000000,"shares":879967700,"eps":0.5892348126952142,"marketStatus":"交易中","change":0.36,"latestTime":"05-06 13:44:31","open":12.54,"high":12.94,"low":12.34,"amount":50791116,"amplitude":0.047847,"askPrice":12.92,"askSize":135800,"bidPrice":12.9,"bidSize":3800,"shortable":3,"etf":0,"ttmEps":0.5892348126952142,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746519000000},"marketStatusCode":2,"adr":0,"listingDate":1451318400000,"exchange":"SEHK","adjPreClose":12.54,"openAndCloseTimeList":[[1746495000000,1746504000000],[1746507600000,1746518400000]],"volumeRatio":1.08085,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01558/tweets","defaultTab":"tweets","newsList":[{"id":"2531406705","title":"研究结果亮相国际会议！东阳光药2款创新药临床前研究登陆2025 AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2531406705","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531406705?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:36","pubTimestamp":1745998583,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年4月25日至30日，备受瞩目的第116届美国癌症研究协会年会在美国芝加哥盛大召开。东阳光药2款创新药——靶向LY6G6D阳性肿瘤细胞和免疫细胞表面激活型共刺激分子双特异性抗体HEC-921、pan KRAS抑制剂HEC211909的临床前研究亮相本次会议，旨在加速推动临床转化和全球合作，彰显公司研发实力获得国际同行认可!相较于HRAS和NRAS，HEC211909对KRAS表现出高度选择性。临床前显示具有良好的药代动力学特征。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01558","BK0070","600673","BK0012","06978","BK1515","BK0003","BK0028","BK1191","BK0188","BK0265","BK1574","BK1161","159992"],"gpt_icon":0},{"id":"2530991894","title":"东阳光长江药业盘中异动 大幅跳水6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530991894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530991894?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:30","pubTimestamp":1745803807,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时30分，东阳光长江药业股票出现异动，股价急速跳水6.39%。东阳光长江药业股票所在的药品行业中，整体跌幅为0.46%。其相关个股中，康龙化成、四环医药、海王英特龙涨幅较大，振幅较大的相关个股有三生制药、康臣药业、中国生物制药，振幅分别为2.30%、1.47%、1.01%。东阳光长江药业公司简介：宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093007aa2c7c32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093007aa2c7c32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2529624843","title":"东阳光长江药业盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529624843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529624843?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:32","pubTimestamp":1745285557,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时32分，东阳光长江药业股票出现波动，股价快速拉升5.04%。截至发稿，该股报12.500港元/股，成交量190.34万股，换手率0.29%，振幅4.71%。东阳光长江药业股票所在的药品行业中，整体涨幅为0.25%。其相关个股中，远大医药、三生制药、信达生物涨幅较大，振幅较大的相关个股有远大医药、先声药业、东阳光长江药业，振幅分别为5.22%、4.83%、4.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093237973ff77f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093237973ff77f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2527461750","title":"东阳光长江药业04月15日主力净流出120万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527461750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527461750?lang=zh_cn&edition=full","pubTime":"2025-04-15 16:17","pubTimestamp":1744705020,"startTime":"0","endTime":"0","summary":"04月15日，东阳光长江药业股价收平报11.50元，成交金额1.06亿元，换手率1.40%，振幅3.48%，量比0.85。东阳光长江药业今日主力资金净流出120万元，上一交易日主力净流入470万元。该股近5个交易日上涨27.78%，主力资金累计净流入4754万元；近20日主力资金累计净流入2400万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171823a4597dff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171823a4597dff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2517410932","title":"东阳光长江药业03月07日遭主力抛售120万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517410932?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335465,"startTime":"0","endTime":"0","summary":"03月07日, 东阳光长江药业股价跌1.52%，报收9.69元，成交金额2287万元，换手率0.36%，振幅2.85%，量比0.99。东阳光长江药业今日主力资金净流出120万元，连续7日净流出，上一交易日主力净流出53万元。该股近5个交易日下跌0.21%，主力资金累计净流出607万元，其中3个交易日为股价上涨时净流出；近20日主力资金累计净流入2089万元，其中净流入天数为8日。该股主力净额占比0.02%，港股市场排名2405/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307171306abeccb86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307171306abeccb86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01558","BK1191"],"gpt_icon":0},{"id":"2517149194","title":"港股概念追踪|Deepseek掀起AI医疗热潮     提升医药板块估值（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2517149194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517149194?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:41","pubTimestamp":1741311687,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，DeepSeek掀起AI医疗热潮，提升医药板块估值。近日，医渡科技宣布已将DeepSeek人工智能模型整合至公司自主研发的\"AI医疗大脑\"YiduCore，将进一步推动AI技术在医疗健康产业的规模化应用与创新实践。通过整合DeepSeek的强大算力与算法优势，AI技术在医疗服务中的深入应用，平安健康的用户规模和收入水平有望进一步提升，从而推动公司估值的增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YANG","09939","02506","01558","159938","HSTECH","159891","HSCEI"],"gpt_icon":1},{"id":"2514315290","title":"东阳光长江药业盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514315290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514315290?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:39","pubTimestamp":1740728391,"startTime":"0","endTime":"0","summary":"2025年02月28日临近收盘15时39分，东阳光长江药业股票出现波动，股价快速跳水5.07%。截至发稿，该股报9.740港元/股，成交量334.4万股，换手率0.51%，振幅4.29%。东阳光长江药业股票所在的药品行业中，整体跌幅为0.94%。东阳光长江药业公司简介：宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281539519633a039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281539519633a039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2513794176","title":"AI医疗“技术+场景”生态持续完善，东阳光长江药业(01558)有望引领创新药研发新浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2513794176","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513794176?lang=zh_cn&edition=full","pubTime":"2025-02-24 12:56","pubTimestamp":1740372993,"startTime":"0","endTime":"0","summary":"东阳光药选择以AI技术为核心，重构药物研发全流程。通过上述AI技术手段，公司最终确定具有良好体内外药效、成药性和安全性的候选药物HEC169584。目前国内尚无同类药物上市，HEC169584有望快速推进临床，为患者带来新的治疗选择。在政策利好下，国内AI医疗行业的市场规模正迎来快速增长。站在AI医疗的爆发拐点，东阳光药的探索为行业提供了宝贵经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01558","BK1191","06978","BK1574","BK1161","BK1515","159891","159992"],"gpt_icon":0},{"id":"2512466404","title":"东阳光长江药业现涨近6% 将DeepSeek大模型全面接入HEC-Finder平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2512466404","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512466404?lang=zh_cn&edition=full","pubTime":"2025-02-20 10:58","pubTimestamp":1740020280,"startTime":"0","endTime":"0","summary":"　　东阳光长江药业早盘上涨5.63%，现报10.50港元，成交额6296.29万港元。　　东阳光药日前公布启动AI+全面战略布局。据悉，东阳光药与深势科技合作，构建了新一代AI文献与专利数据库检索、问答、分析管理大模型平台——HEC-Finder。该平台聚焦药物研发，为科研人员提供科学文献的智能检索、分析及关键信息提取等功能，助力研发效率提升。东阳光药已将DeepSeek大模型全面接入HEC-Finder平台，充分释放AI在文献专利智能应用的潜能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-20/doc-inemawin4889841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01558"],"gpt_icon":0},{"id":"2512465803","title":"港股异动 | 东阳光长江药业(01558)涨超6% 将DeepSeek大模型全面接入HEC-Finder平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2512465803","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512465803?lang=zh_cn&edition=full","pubTime":"2025-02-20 10:22","pubTimestamp":1740018146,"startTime":"0","endTime":"0","summary":"消息面上，东阳光药日前公布启动AI+全面战略布局。据悉，东阳光药与深势科技合作，构建了新一代AI文献与专利数据库检索、问答、分析管理大模型平台——HEC-Finder。东阳光药已将DeepSeek大模型全面接入HEC-Finder平台，充分释放AI在文献专利智能应用的潜能。此外，公司表示，在不断优化模型的同时，也全力推进AI工具在办公、生产、销售等各业务环节进行深入应用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01558"],"gpt_icon":0},{"id":"2512450675","title":"东阳光长江药业盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512450675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512450675?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:39","pubTimestamp":1740015551,"startTime":"0","endTime":"0","summary":"2025年02月20日早盘09时39分，东阳光长江药业股票出现波动，股价大幅上涨5.03%。截至发稿，该股报10.440港元/股，成交量178.3万股，换手率0.27%，振幅5.03%。东阳光长江药业股票所在的药品行业中，整体涨幅为0.07%。东阳光长江药业公司简介：宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220093911988bad55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220093911988bad55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2512317897","title":"东阳光长江药业02月19日获主力加仓514万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512317897","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512317897?lang=zh_cn&edition=full","pubTime":"2025-02-19 16:17","pubTimestamp":1739953023,"startTime":"0","endTime":"0","summary":"02月19日, 东阳光长江药业股价涨0.20%，报收9.94元，成交金额4418万元，换手率0.68%，振幅2.12%，量比1.29。东阳光长江药业今日主力资金净流入514万元，连续4日净流入，上一交易日主力净流入110万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为80.00%，平均涨幅为3.27%。该股近5个交易日上涨7.46%，主力资金累计净流入928万元；近20日主力资金累计净流入613万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219161813a24b995c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219161813a24b995c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2512111961","title":"中国内地投资者周二港股通净买入额创四年来最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512111961?lang=zh_cn&edition=full","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票，继续推动DeepSeek引发的科技股涨势。彭博数据显示，这是自2021年初以来最大单日净买入，也是有纪录以来第四高。恒生科技指数当日大涨2.5%，有望连续第六周上涨。内地资金大量涌入香港股市，已推动A股市场相较港股的溢价幅度缩小至约34%，这使得一项A-H股溢价指数接近在过去总会触发反弹的底部，引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06818","01772","02018","09922","00412","00467","00175","00013","01177","01919","00981","01530","BK1589","01787","01119","00006","00303","00548","02105","09992","01735","01929","01818","00384","02268","01093","02157","01658","01138","02498","03690","01558","00293","01405","02096","02208","02883","00728","02186","01112","02380","01691","06680","00762","01052","02601","02386","01199","00659","01921","BK1133","01952","00008","02400","06110","00144","00751","09696","09969","01686","HSCEI","09926","02359","00512","06821","01579","06699","01347","01070","01513","01888","03618","00142","02121","03369","HSTECH","02155","09868","01541","00189","BK1506","02016","09987","00177","01066","02338","02282","01128","06060","06855","01519","02402","01907","01789","09626","00288","02005","BK1536","03918","03988","01357","02688","03360","06990","00005","01876","06936","09923","00014","06181","00836","00392","03800","00316","00270","00861","02172","00327","01193","03606","02171","00788","00867","00152","00855","09880","09885","01071","02618","06690","00425","06808","01766","09858","00241","02291","00038","00220","01310","01618","02533","01855","00267","01860","02057","03933","03396","06198","01585","00148","00666","00003","SG9999002463.SGD","09899","00777","00826","00590","01341","02600","02162","02607","01024","09688","00546","01211","02099","00257","00939","00371","06616","00868","03650","06127","02367","02333","09890","00300","02269","00317","00856","00772","01810","00853","02465","00991","02158","03692","06618","00576","02382","01963","01675","09995","06069","03968","00107","02015","06186","03969","03888","06160","09988","03311","03328","00819"],"gpt_icon":0},{"id":"2510395500","title":"南向资金2月11日净买入东阳光长江药业11.72万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2510395500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510395500?lang=zh_cn&edition=full","pubTime":"2025-02-12 09:30","pubTimestamp":1739323822,"startTime":"0","endTime":"0","summary":"2月11日, 南向资金增持东阳光长江药业11.72万股，连续3日增持。截止当日收盘，港股通共持有东阳光长江药业14790.78万股，占流通股22.61%。港股通增持金额前五个股分别为阿里巴巴-W、比亚迪股份、联想集团、工商银行、速腾聚创。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212093226abcb951f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212093226abcb951f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2510182401","title":"AI医疗或成下一个投资风口，东阳光长江药业(01558)依托先发优势打开估值上升通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2510182401","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510182401?lang=zh_cn&edition=full","pubTime":"2025-02-11 14:01","pubTimestamp":1739253709,"startTime":"0","endTime":"0","summary":"在此轮AI行情中，多家信息技术企业作为AI赛道新品种已获市场成功挖掘，而AI医疗则有可能成为下一个爆发的风口。去年12月16日，东阳光药基于AI驱动的1类新药、首个小分子创新药HEC169584获批，用于非酒精性脂肪性肝炎的临床试验。通过上述AI技术手段，公司最终确定具有良好体内外药效、成药性和安全性的候选药物HEC169584。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01558","159891","BK1191"],"gpt_icon":0},{"id":"2510085907","title":"东阳光药1类丙肝新药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2510085907","media":"健识局","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510085907?lang=zh_cn&edition=full","pubTime":"2025-02-10 20:16","pubTimestamp":1739189805,"startTime":"0","endTime":"0","summary":"近日，据NMPA 官网显示，东阳光药 1 类新药磷酸萘坦司韦胶囊，该药适用于与艾考磷布韦片联用，治疗初治或干扰素经治的基因1、2、3、6型成人慢性丙型肝炎病毒感染，可合并或不合并代偿性肝硬化。根据东阳光药公开资料，磷酸萘坦司韦为NS5A抑制剂，艾考磷布韦为NS5B抑制剂，这两款药均为东阳光药自主研发的1类新药。丙型肝炎病毒是一种常见的血源性病原体，其主要感染部位是肝脏。积极预防、尽早发现、及早治疗是控制丙肝的关键措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210203520abc989ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210203520abc989ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2510070461","title":"20亿销售潜力丙肝新药顺利上市，东阳光长江药业(01558)价值曲线再添新坐标","url":"https://stock-news.laohu8.com/highlight/detail?id=2510070461","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510070461?lang=zh_cn&edition=full","pubTime":"2025-02-10 10:15","pubTimestamp":1739153741,"startTime":"0","endTime":"0","summary":"市场预计，艾考磷布韦片有望于本月内获批上市，成为东阳光药今年上市的第二款丙肝治疗药物。此前针对我国主要流行的丙型肝炎病毒基因1型，东阳光药已于2020年12月上市了一款NS5A抑制剂磷酸依米他韦(东卫恩)。而随着磷酸安泰他韦联合艾考磷布韦片方案的两款药物顺利获批上市，东阳光药将成为国内唯一拥有自主全基因丙肝组合的企业。市场预计，中国丙肝药物市场规模将从2019年的20亿元增至2025年的100亿元，年复合增长率超30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK0264","BK0256","01558","BK1191","603040"],"gpt_icon":0},{"id":"2509056704","title":"东阳光长江药业续签2025年分成协议 最高分成7000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509056704","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509056704?lang=zh_cn&edition=full","pubTime":"2025-02-08 10:00","pubTimestamp":1738980016,"startTime":"0","endTime":"0","summary":"财中社2月8日电东阳光长江药业（01558）发布公告，宣布与广东东阳光药业续订2025年分成协议。该协议自2025年2月7日起至2025年12月31日止，主要涉及广东东阳光药业向公司分配其销售指定药品所产生的收入或利润。根据协议，广东东阳光药业应向公司分配自指定药品销售产生的销售收入的10%（集采业务）和70%（非集采业务）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502083313985816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2509912057","title":"东阳光长江药业（01558.HK）2月7日收盘上涨0.32%，成交2227.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509912057","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509912057?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:44","pubTimestamp":1738917870,"startTime":"0","endTime":"0","summary":"2月7日，截至港股收盘，恒生指数上涨1.16%，报21133.54点。东阳光长江药业收报9.36港元/股，上涨0.32%，成交量238.5万股，成交额2227.76万港元，振幅2.79%。财务数据显示，截至2024年6月30日，东阳光长江药业实现营业总收入24.55亿元，同比减少23.5%；归母净利润6.85亿元，同比减少33.49%；毛利率79.41%，资产负债率30.64%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/07164448014580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2505174372","title":"东阳光长江药业01月21日主力资金流出3万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2505174372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505174372?lang=zh_cn&edition=full","pubTime":"2025-01-21 16:16","pubTimestamp":1737447416,"startTime":"0","endTime":"0","summary":"01月21日, 东阳光长江药业股价涨0.32%，报收9.52元，成交金额1012万元，换手率0.16%，振幅1.69%，量比0.52。东阳光长江药业今日主力资金净流出3万元，连续3日净流出，上一交易日主力净流出100万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为81.25%，平均跌幅为1.56%。该股近5个交易日下跌2.56%，主力资金累计净流出214万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出289万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121161721a229ea57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121161721a229ea57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hec-changjiang.com","stockEarnings":[{"period":"1week","weight":0.0279},{"period":"1month","weight":0.2515},{"period":"3month","weight":0.3645},{"period":"6month","weight":0.3902},{"period":"1year","weight":-0.0398},{"period":"ytd","weight":0.3117}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":-0.0301},{"period":"3month","weight":0.1127},{"period":"6month","weight":0.0974},{"period":"1year","weight":0.236},{"period":"ytd","weight":0.1219}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。其业务还包括药品的研发、营销及分销。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。其核心产品组合包括“可威”、“尔同舒”、“欧美宁”、“欣海宁”及 “喜宁”。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.043067},{"month":2,"riseRate":0.8,"avgChangeRate":0.085582},{"month":3,"riseRate":0.4,"avgChangeRate":-0.060003},{"month":4,"riseRate":0.7,"avgChangeRate":0.045268},{"month":5,"riseRate":0.5,"avgChangeRate":-0.016051},{"month":6,"riseRate":0.666667,"avgChangeRate":0.070024},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.05594},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.04223},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.045743},{"month":10,"riseRate":0.444444,"avgChangeRate":0.024617},{"month":11,"riseRate":0.777778,"avgChangeRate":0.132165},{"month":12,"riseRate":0.555556,"avgChangeRate":0.011051}],"exchange":"SEHK","name":"东阳光长江药业","nameEN":"HEC CJ PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光长江药业,01558,东阳光长江药业股票,东阳光长江药业股票老虎,东阳光长江药业股票老虎国际,东阳光长江药业行情,东阳光长江药业股票行情,东阳光长江药业股价,东阳光长江药业股市,东阳光长江药业股票价格,东阳光长江药业股票交易,东阳光长江药业股票购买,东阳光长江药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}